These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1431014)
1. A review of the psychomotor effects of paroxetine. Hindmarch I Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():65-7. PubMed ID: 1431014 [TBL] [Abstract][Full Text] [Related]
2. The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly. Kerr JS; Fairweather DB; Mahendran R; Hindmarch I Int Clin Psychopharmacol; 1992 Nov; 7(2):101-8. PubMed ID: 1487621 [TBL] [Abstract][Full Text] [Related]
3. Sleep and paroxetine: a comparison with mianserin in elderly depressed patients. Dorman T Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():53-8. PubMed ID: 1431012 [TBL] [Abstract][Full Text] [Related]
4. Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. Robbe HW; O'Hanlon JF Eur Neuropsychopharmacol; 1995 Mar; 5(1):35-42. PubMed ID: 7613099 [TBL] [Abstract][Full Text] [Related]
5. Paroxetine in the treatment of elderly depressed patients in general practice: a double-blind comparison with amitriptyline. Hutchinson DR; Tong S; Moon CA; Vince M; Clarke A Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():43-51. PubMed ID: 1431010 [TBL] [Abstract][Full Text] [Related]
6. A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. Italian Paroxetine Study Group. Bignamini A; Rapisarda V Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():37-41. PubMed ID: 1431009 [TBL] [Abstract][Full Text] [Related]
7. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients. Stuppaeck CH; Geretsegger C; Whitworth AB; Schubert H; Platz T; König P; Hinterhuber H; Fleischhacker WW J Clin Psychopharmacol; 1994 Aug; 14(4):241-6. PubMed ID: 7962679 [TBL] [Abstract][Full Text] [Related]
8. Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients. Möller HJ; Berzewski H; Eckmann F; Gonzalves N; Kissling W; Knorr W; Ressler P; Rudolf GA; Steinmeyer EM; Magyar I Pharmacopsychiatry; 1993 May; 26(3):75-8. PubMed ID: 8415897 [TBL] [Abstract][Full Text] [Related]
10. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects. Geretsegger C; Böhmer F; Ludwig M Int Clin Psychopharmacol; 1994; 9(1):25-9. PubMed ID: 8195578 [TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treated in general practice. Trick L; Stanley N; Rigney U; Hindmarch I J Psychopharmacol; 2004 Jun; 18(2):205-14. PubMed ID: 15260909 [TBL] [Abstract][Full Text] [Related]
12. Paroxetine and amitriptyline in the treatment of depression in general practice. Christiansen PE; Behnke K; Black CH; Ohrström JK; Bork-Rasmussen H; Nilsson J Acta Psychiatr Scand; 1996 Mar; 93(3):158-63. PubMed ID: 8739658 [TBL] [Abstract][Full Text] [Related]
13. A comparison of paroxetine and placebo in depressed outpatients. Dunbar GC; Claghorn JL; Kiev A; Rickels K; Smith WT Acta Psychiatr Scand; 1993 May; 87(5):302-5. PubMed ID: 8517168 [TBL] [Abstract][Full Text] [Related]
14. Paroxetine and amitriptyline augmentation of lithium in the treatment of major depression: a double-blind study. Bauer M; Zaninelli R; Müller-Oerlinghausen B; Meister W J Clin Psychopharmacol; 1999 Apr; 19(2):164-71. PubMed ID: 10211918 [TBL] [Abstract][Full Text] [Related]
15. Paroxetine in Parkinson's disease: effects on motor and depressive symptoms. Ceravolo R; Nuti A; Piccinni A; Dell'Agnello G; Bellini G; Gambaccini G; Dell'Osso L; Murri L; Bonuccelli U Neurology; 2000 Oct; 55(8):1216-8. PubMed ID: 11071504 [TBL] [Abstract][Full Text] [Related]
16. Heart rate variability in depressed patients and differential effects of paroxetine and amitriptyline on cardiovascular autonomic functions. Rechlin T; Weis M; Claus D Pharmacopsychiatry; 1994 May; 27(3):124-8. PubMed ID: 8078953 [TBL] [Abstract][Full Text] [Related]
17. Psychomotor and memory effects of haloperidol, olanzapine, and paroxetine in healthy subjects after short-term administration. Morrens M; Wezenberg E; Verkes RJ; Hulstijn W; Ruigt GS; Sabbe BG J Clin Psychopharmacol; 2007 Feb; 27(1):15-21. PubMed ID: 17224707 [TBL] [Abstract][Full Text] [Related]
18. The effects of acute and repeated doses of suriclone on subjective sleep, psychomotor performance and cognitive function in young and elderly volunteers. Gilburt SJ; Fairweather DB; Kerr JS; Hindmarch I Fundam Clin Pharmacol; 1992; 6(6):251-8. PubMed ID: 1362556 [TBL] [Abstract][Full Text] [Related]
19. A study comparing paroxetine placebo and imipramine in depressed patients. Feighner JP; Cohn JB; Fabre LF; Fieve RR; Mendels J; Shrivastava RK; Dunbar GC J Affect Disord; 1993 Jun; 28(2):71-9. PubMed ID: 8354771 [TBL] [Abstract][Full Text] [Related]
20. Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. Nebes RD; Pollock BG; Houck PR; Butters MA; Mulsant BH; Zmuda MD; Reynolds CF J Psychiatr Res; 2003; 37(2):99-108. PubMed ID: 12842163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]